Description
Unlocking the Potential of Frag 176-191: A Breakthrough in Lipolysis
Frag 176-191 stands as a groundbreaking advancement in the realm of fat metabolism. Derived from a modified amino acid sequence of growth hormone, Frag 176-191 has garnered significant attention for its lipolytic activity, as evidenced by numerous published studies. This compound operates directly on adipose fat tissues, fostering increased lipolysis and decreased lipogenesis.
With research efforts dating back to the early 1970s, Frag 176-191 has been subject to thorough investigation, revealing its rich composition of proline and proteases, as highlighted in a seminal study published in 1984. Notably, despite mimicking the properties of growth hormones, Frag 176-191 distinguishes itself by exerting no influence on blood glucose levels.
Characterized by a molecular weight of 1817.12 and a molecular formula of C78H125N23O23S2, Frag 176-191 represents the epitome of efficacy and purity, boasting a peptide purity exceeding 99.0%.
Frag 176-191 Chemical Profile:
- Formula: C78H125N23O23S2
- Molecular weight: 1817.12
- Peptide purity: > 99.0%
- Chain: H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH